Adalimumab Drug Level ELISA (IDKmonitor®)

Product code: K9657 (96 wells)

Determination of free therapeutic adalimumab

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free therapeutic TNFα antibodies (adalimumab) from plasma or serum samples. This test quantifies the amount of free adalimumab to evaluate drug efficacy and investigate primary non-response and loss of response, and can be used by both gastroenterology and rheumatology departments.

The assay is widely available throughout the UK and Ireland to both routine clinical laboratories as well as for research applications. Please contact us for your nearest test reference laboratory. This kit is supported by UK publications and evidence base.

Download Brochure
Technical Support
Request a Quote

Key Advantages

Highly specific quantification of adalimumab, with no cross reaction with infliximab, golimumab and other plasma proteins
Total incubation time 130 minutes
Saves costs by predicting efficacy of adalimumab treatment and stratifying patients accordingly
Reportable range 0.58-45 ug/ml
Automatable on ELISA automates (e.g. Dynex DS2)

Specifications

ELISA

40 tests

Storage: 2-8 °C

Blood sample

Related Products

    076-20-Adalimumab-Free-Anti-drug-ELISA-IDKmonitor

    Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

    Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

    076-20-Adalimumab-Total-Anti-drug-ELISA-IDKmonitor

    Adalimumab Total Anti-drug Antibody ELISA (IDKmonitor®)

    Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.